Professor Dean Fennell

Tackling hard-to-treat lung cancers

Professor Fennell and his team are testing new treatments for people with mesothelioma , a type of lung cancer usually caused by exposure to asbestos, and for people with non-small cell lung cancer who have mistakes in their BRCA1 gene.

He’s also involved with Tracer X , a landmark Cancer Research UK-funded project tracking how lung cancers change over time and become resistant to treatment.

Lung cancer is the second most common cancer in the UK, claiming tens of thousands of lives every year in the UK. Improving survival from lung cancer is one of our key priorities, and clinical trials like Professor Fennell’s are urgently needed to bring new treatments to people with this disease.

Read more about Professor Fennell's research here.

Lung cancer
Clinical trials

University of Leicester, Leicester